January 14, 2026
2025 Year in Review: Regulatory Shake-Ups Reshaping Pharma Promotion in 2026
Explore 2025's FDA enforcement trends, OPDP changes, and evolving guidance shaping pharma advertising, MLR review, and compliance strategies for 2026.
Advancing Obesity Treatments with Expert Support
The obesity drug market is experiencing unprecedented growth, driven by the success of groundbreaking treatments. As more pharmaceutical companies, especially smaller and mid-sized firms, seek to contribute to this dynamic field, the need for expertly managed clinical trials and customized patient support has never been more critical. ProPharma offers specialized services to help you navigate the complexities of obesity clinical trials and compound drug management, ensuring your study and services effective treatments to patients who need them.
Navigating the Challenges of Rapid Enrollment
One of the primary challenges in obesity clinical trials or treatment initiation is the speed at which enrollment can occur. Rapid enrollment is a double-edged sword; while it can accelerate your timeline, it also requires a robust monitoring strategy to maintain the integrity of your data and treatment success. ProPharma's experienced team ensures your trial is equipped with a proactive monitoring approach that adapts to fast-paced enrollments, minimizing risks and maintaining the highest quality standards.
Accelerate Obesity & Diabetes Clinical Trials and Post Market Treatments
ProPharma has the expertise to accelerate obesity clinical trials by offering comprehensive regulatory support and biostatistical expertise in trial design. In a competitive landscape where many seek obesity drug approvals, our ability to expedite the process is a key differentiator. Additionally, we provide in-house medical and regulatory expertise to efficiently manage and execute these trials, helping you bring your drug to the market faster.
ProPharma also has a proven high-quality worldwide contact center to support obesity treatment management, including customized patient support for clinical trials, commercials, and compounded products. Our medical information and patient support experts deliver excellent patient-centric treatment logistics to ensure that patients meet their goal of weight management safely and effectively.
Decentralized Clinical Trials
ProPharma's decentralized clinical trials (DCTs) offer a more flexible approach to executing trials, allowing sponsors to reach diverse populations and patients who may not have access to traditional trial sites. By utilizing virtual, remote, or hybrid models, ProPharma facilitates easier participation while maintaining regulatory compliance and data integrity. This approach reduces geographic barriers, accelerates patient recruitment, and enhances engagement, leading to more efficient and inclusive trial execution and ultimately improving trial outcomes.
Why Choose ProPharma?
Proven Experience
Decades of experience managing obesity clinical trials across diverse populations.
Patient-Centric Approach
Focused on minimizing patient burden to improve retention and data quality.
Innovative Strategies
Cutting-edge monitoring and engagement strategies to manage rapid enrollment and minimize dropout rates.
Global Reach
A worldwide network of sites and regulatory expertise to support your trial across multiple regions.
News & Insights
Thought Leadership Webinars Press Awards Resource Library
December 22, 2025
Understanding FDA Requirements for Medical Information Services in the US
Learn about FDA requirements for medical information services in the US and how MI teams ensure compliance and protect public health through proper reporting and documentation practices.
December 15, 2025
Annex 11 2011 Version vs. Annex 11 2025 Draft Version: What are the Differences ...
Discover the key differences and enhancements between Annex 11 2011 and the 2025 draft version for computerised systems in GMP-regulated environments.
-1.png?width=320&height=185&name=4%20-%20Quality%20%26%20Compliance%20(1)-1.png)
News & Insights
December 11, 2025
ProPharma Expands Operations with New Office in Hyderabad
ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.
December 4, 2025
ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions
ProPharma taps Daniel Ryan as President of Clinical Research Solutions, strengthening its clinical trial management leadership and expanding its FSP Solutions.
July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
